More Business Wire
View Older Stories View Newer Stories-
PureTech Presents Data for LYT-200 (anti-galectin-9 monoclonal antibody) for Relapsed/Refractory AML/MDS at the 2024 ASH Annual Meeting
-
Ferguson Files Form 8-K
-
Poxel Reports Financial Results for First Half 2024 and Provides an Update on its Financial Position and Outlook
-
Innate Pharma Presents Lacutamab Improved Health-related Quality of Life Data at ASH 2024 From TELLOMAK Phase 2 Study in Patients With Cutaneous T Cell Lymphoma
-
Leukogene Therapeutics Welcomes Industry Veteran and Leader Dr. Sandeep Gupta as Its Chief Executive Officer
-
Nearshoring Trend Continues as CTP Signs 19,000 sqm Deal With Chinese Manufacturer in Serbia
-
Walmart Delivers Last-Minute Savings and Convenience with Holiday Grand Finale
-
Arcellx Announces New Positive Data for Its iMMagine-1 Study in Patients With Relapsed or Refractory Multiple Myeloma to be Presented During an Oral Presentation at the 66th ASH Annual Meeting and Exp
-
FPT and RWE Sign 5-Year Master Service Agreement to Drive Innovation and Sustainability
-
Be Biopharma Unveils BeCoMe-9 Trial and Presents on Versatile B Cell Medicines Platform at ASH 2024
-
Apple announces Apple Retail expansion in the Kingdom of Saudi Arabia
-
New Results Show Donor Search Prognosis Score Equalizes Transplant Outcomes at American Society of Hematology Annual Meeting 2024
-
Orca Bio Presents Three-Year Survival Data with Orca-T® in Patients with Hematological Malignancies at the 66th ASH Annual Meeting
-
Merck’s Investigational Zilovertamab Vedotin in Combination With R-CHP Demonstrates Complete Response Rate of 100% at 1.75 mg/kg Dose in Phase 2 Trial of Previously Untreated Patients With Diffuse L
-
Vertex Presents Positive Long-Term Data On CASGEVY™ (exagamglogene autotemcel) at the American Society of Hematology (ASH) Annual Meeting and Exposition and Provides Program Update
-
Kite Presents New Data Underscoring Curative Potential of Yescarta® in Relapsed/Refractory Large B-cell Lymphoma at ASH
-
Five-Year Results Confirm Genentech’s Polivy Combination Therapy as New Standard of Care for Previously Untreated Aggressive Lymphoma
-
bluebird bio Presents Positive Long-Term Data On LYFGENIA™ (lovotobegligene autotemcel) Gene Therapy for Sickle Cell Disease at 66th American Society of Hematology (ASH) Annual Meeting and Expositio
-
ReAlta Life Sciences Announces Positive Preclinical Data for RLS-0071 (pegtarazimod) in Acute Graft-Versus-Host Disease (aGVHD) at American Society of Hematology Annual Meeting
-
Fixed-duration CALQUENCE plus venetoclax demonstrated superior PFS vs. standard of care in previously untreated CLL, with 77% of patients progression free at three years in AMPLIFY Phase III trial
-
Investigational Epcoritamab (DuoBody® CD3xCD20) Combination Therapy Demonstrates High Response Rates in Clinical Trial of Patients With Relapsed or Refractory (R/R) Follicular Lymphoma (FL)
-
Orca Bio Presents Clinical Results on Use of Orca-Q® without GvHD Prophylaxis in Patients with Hematological Malignancies at the 66th ASH Annual Meeting
-
Twenty-three Years Running for the Kids of St. Jude: St. Jude Memphis Marathon Weekend Reaches Fundraising Record
-
Long-Term Follow-Up Data Continue to Support Beti-Cel as a Potentially Curative Gene Therapy for β-Thalassemia Patients Who Require Regular Transfusions Through Achievement of Durable Transfusion Ind
-
MiNA Therapeutics Presents New Pre-Clinical Data from Lead Sickle Cell Disease Program at the American Society of Hematology Annual Meeting
-
City of Hope Scientists Present Innovative Research on How High-Fiber Diets Can Improve Outcomes in Cancer Care
-
Granada on Broadway, AHF Host Screening of New Film on Homelessness
-
University of Phoenix College of Doctoral Studies Celebrates a Robust 2024 Knowledge Without Boundaries Summit With Record 1,000+ Attendees
-
Incyte Announces Positive Results from Phase 3 Trial Evaluating Retifanlimab (Zynyz®) in Combination with Platinum-Based Chemotherapy in Patients with Non-Small Cell Lung Cancer
-
BW LPG Limited - BW LPG Takes Delivery of Vessel BW Pampero from Avance Gas
-
Late St. Jude Memphis Marathon Director Honored with Hero Among Us Award
-
Comcast Premieres "Our Blues Make Us Gold," A Compelling Documentary Celebrating North Carolina A&T's Global Impact and Historic Legacy
-
Nasdaq Staff Determination Letter
-
Janux Therapeutics Announces Closing of Underwritten Public Offering of Common Stock and Pre-Funded Warrants Including Full Exercise of Underwriters’ Option to Purchase Additional Shares for Total G
-
Statement from RealPage: U.S. Department of Justice Terminates its Investigation of Multifamily Rental Housing Pricing Practices
-
Varex to Hold Virtual Annual Meeting of Stockholders and Sets Annual Meeting and Record Dates
-
Walmart, Amazon, Apple Dominate Black Friday/Cyber Monday Spending Among Paycheck to Paycheck Shoppers, New Data from Brigit Reveals
-
Lisa Vanderpump Throws an Epic Grand Opening Party For Pinky’s by Vanderpump at Flamingo Las Vegas
-
Gensource Potash Corporation Announces Granting of Stock Options
-
KBRA Releases Research – Third-Quarter 2024 Business Development Company (BDC) Ratings Compendium
-
Golden Minerals Announces NYSE American Notice to Commence Delisting and Intended Transition to OTCQB Market
-
TomaGold Announces Proposed Private Placement and Proposed Debt Settlement
-
BILL Announces Closing of Offering of $1.4 Billion of 0% Convertible Senior Notes due 2030, Including Full Exercise of Initial Purchasers’ $150.0 Million Option to Purchase Additional Notes
-
Syntheia Commences SOC 2 Type I Certification, Reinforcing Commitment to Data Privacy and Security
-
Liberty Media Appoints Chase Carey to Board of Directors
-
Illinois American Water Granted New Rates by Illinois Commerce Commission
-
Automation Personnel Services Earns Best Staffing Agency Recognition In 3 Markets
-
Enanta Pharmaceuticals to Present Topline Results from First-in-Pediatrics Phase 2 Study Evaluating Zelicapavir for Respiratory Syncytial Virus (RSV)
-
Anduril and Palantir to Accelerate AI Capabilities for National Security
-
State Street Corporation (NYSE: STT) Announces Date for Release of Fourth-Quarter and Full-Year 2024 Financial Results and Conference Call Webcast
